Xichen Lin
Chief Scientific Officer at Structure Therapeutics Inc. (GPCR)
Xichen Lin has filed 13 insider reports with the SEC since March 2024, as chief Scientific Officer at Structure Therapeutics Inc. (GPCR). The latest filing, on September 3, 2026, reports conversion of a derivative, exercise or conversion of a derivative and open-market sale at Structure Therapeutics Inc. (GPCR).
- Filings
- 13
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Xichen Lin is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Scientific Officer | 228,960 | $18.17 | Sep 3, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 1, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen exercised 17,817 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 18, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen exercised 11,817 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 4, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen exercised 11,817 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 14, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen exercised 23,634 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jun 25, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen exercised 23,634 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 19, 2026GPCRSEC Form 4 filed by Lin XichenForm 4Grant or award
- Mar 3, 2026GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen covered exercise/tax liability with 18,735 units of Ordinary Shares, decreasing direct ownership by 9% to 185,592 unitsForm 4Shares withheld for taxes or exercise price
- Jul 1, 2025GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen covered exercise/tax liability with 12,846 units of Ordinary Shares, decreasing direct ownership by 6% to 204,327 unitsForm 4Shares withheld for taxes or exercise price
- Jul 1, 2025GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen covered exercise/tax liability with 6,441 units of Ordinary Shares and was granted 57,078 units of Ordinary Shares, increasing direct ownership by 30% to 217,173 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Mar 15, 2025GPCRCHIEF SCIENTIFIC OFFICER Lin Xichen was granted 80,829 units of Ordinary Shares, increasing direct ownership by 94% to 166,536 unitsForm 4Grant or award
- Jun 3, 2024GPCRLin Xichen exercised 106,200 units of Ordinary Shares at a strike of $0.34Form 4Conversion of a derivativeExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Mar 15, 2024GPCRSEC Form 4 filed by Lin Xichen (Amendment)Form 4Grant or award
- Mar 15, 2024GPCRLin Xichen was granted 85,707 units of Ordinary SharesForm 4Grant or award
Compare Xichen Lin with
- Xichen Lin vs Crespo Blas Coll1 shared
- Xichen Lin vs John Joseph Berrios1 shared
- Xichen Lin vs Angus C. Russell1 shared
- Xichen Lin vs Ted W Love1 shared
- Xichen Lin vs Joanne Waldstreicher1 shared
- Xichen Lin vs Eric Dobmeier1 shared
Other insiders at the same companies
- Crespo Blas CollGPCR
- John Joseph BerriosGPCR
- Fmr LLCGPCR
- Angus C. RussellGPCR
- Ted W LoveGPCR
- Joanne WaldstreicherGPCR
- Daniel G WelchGPCR
- Eric DobmeierGPCR
- Sharon TetlowGPCR
- Matthew LangGPCR
- Ashley HallGPCR
- Jun YoonGPCR
- Yingli MaGPCR
- Raymond C StevensGPCR
Questions about Xichen Lin
- What is Xichen Lin's role at Structure Therapeutics Inc.?
- Xichen Lin reports to the SEC as chief Scientific Officer at Structure Therapeutics Inc. (GPCR), according to the latest filing on September 3, 2026.
- How many shares does Xichen Lin own?
- After the latest filing that states it, Xichen Lin directly owned 228,960 shares of Structure Therapeutics Inc. (GPCR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Xichen Lin bought or sold stock recently?
- No open-market purchases or sales by Xichen Lin are on file. The filings report conversion of a derivative, exercise or conversion of a derivative, open-market sale and grant or award.
- How do I get alerts when Xichen Lin files?
- Follow Xichen Lin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Xichen Lin filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Xichen Lin (SEC CIK 0001962926). Totals count each trade once, skipping amendments whose original is on file, from Mar 19, 2024 on. View on SEC EDGAR